Role of SUMOylation in Human Oncogenic Herpesvirus Infection

Virus Res. 2020 Jul 2:283:197962. doi: 10.1016/j.virusres.2020.197962. Epub 2020 Apr 11.

Abstract

Post-translational modification of target proteins by the Small Ubiquitin-like Modifier (SUMO) plays a critical role in regulation of many cellular processes including transcription, RNA processing, protein trafficking, DNA repair, and chromosome segregation, and is also often hijacked by viral infections. Epstein-Barr Virus (EBV) and Kaposi's sarcoma-associated Herpesvirus (KSHV), two human oncogenic herpesviruses with a typical life cycle of latent and lytic replication, have been shown to be associated with many human cancers. In the past decade, intensive studies have investigated the interplay between tumor virus infection and SUMO-modification. In this review, we summarize the current knowledge as to how SUMOylation can regulate latent and lytic replication of EBV and KSHV, and the strategies by which these oncogenic herpesviruses usurp the SUMO pathways to establish a favorable microenvironment to promote host cell survival and proliferation in latency, and reactivate virion production during lytic replication, which are critical contributors to the development of EBV/KSHV-associated human malignancies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation, Viral*
  • Herpesviridae / genetics*
  • Herpesviridae Infections / virology
  • Herpesvirus 8, Human / genetics*
  • Humans
  • Mice
  • Protein Processing, Post-Translational
  • Sarcoma, Kaposi / virology
  • Sumoylation / genetics*
  • Viral Proteins / genetics
  • Virus Activation
  • Virus Latency
  • Virus Replication

Substances

  • Viral Proteins